Podcast Episodes
Back to SearchDow’s Record Rally, Rates & Real Estate 12/14/23
The Dow is notching another record high today, as the Post-Fed market rally rolls on. Can stocks keep this momentum going into the new year? We’ll di…
2 years, 7 months ago
Fed holds steady, but rate cuts coming? 12/13/23
The Federal Reserve held its key interest rate steady for the third straight time, but also set the table for multiple cuts to come in 2024 and beyon…
2 years, 7 months ago
Countdown To The Fed, Banking On AI 12/12/23
We’re just 24 hours away from the Fed’s decision on interest rates. No change is expected. But with another tame inflation reading this morning, will…
2 years, 7 months ago
M&A Monday, The $700 Million Man 12/11/23
Today has seen a ton of deal-making news, each highlighting trends across multiple sectors.
Arkhouse Management and Brigade Capital offered to buy Ma…
2 years, 7 months ago
199K Jobs Added, 2 Sides of ‘Gemini’ 12/8/23
The U.S. added 199,000 jobs in November, more than expected and contrary to signs the labor market may be “cooling.” We’ll break down what it means f…
2 years, 7 months ago
Starting To Cool?, CEOs Sound Off 12/7/23
There’s a big jobs report on deck tomorrow, as the labor market is showing signs that it’s starting to cool. We’ll discuss what to expect, and what i…
2 years, 7 months ago
Chips In The Middle, Musk vs. Scandinavia 12/6/23
AMD just unveiled a new AI chip, in a direct challenge to rival Nvidia. We’ll bring you the details.
Plus, striking Swedish mechanics are getting an a…
2 years, 7 months ago
Fear vs. Safety, Grand Plan 12/5/23
Now that interest rates are up, many investors are seeking the safety of bonds or even money market funds. But those who have, also missed out on hug…
2 years, 7 months ago
Losing Steam, On The Defense 12/4/23
Markets are the story today, with stocks heading lower. Is this just a normal pull back in the midst of a larger rally, or a sign markets came too fa…
2 years, 7 months ago
Trial and Error, High-End Holding Up? 12/1/23
Pfizer’s effort to join the weight-loss drug craze just hit a major setback. Patients are quitting its trial after experiencing unpleasant side effec…
2 years, 7 months ago